Moors & Cabot Inc. Has $4.51 Million Position in Colgate-Palmolive (NYSE:CL)

Moors & Cabot Inc. increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,522 shares of the company’s stock after buying an additional 2,137 shares during the period. Moors & Cabot Inc.’s holdings in Colgate-Palmolive were worth $4,514,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CL. Union Savings Bank lifted its holdings in shares of Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares during the period. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive in the second quarter valued at $25,000. PSI Advisors LLC raised its position in Colgate-Palmolive by 4,971.4% during the 1st quarter. PSI Advisors LLC now owns 355 shares of the company’s stock worth $32,000 after purchasing an additional 348 shares during the last quarter. Core Wealth Advisors Inc. lifted its holdings in Colgate-Palmolive by 56.6% during the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock worth $32,000 after buying an additional 146 shares during the period. Finally, Rise Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $38,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.3 %

Shares of Colgate-Palmolive stock opened at $105.43 on Tuesday. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $109.30. The stock has a 50 day moving average price of $102.26 and a two-hundred day moving average price of $95.43. The stock has a market capitalization of $86.50 billion, a PE ratio of 33.36, a price-to-earnings-growth ratio of 3.72 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.77 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 1.90%. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Activity at Colgate-Palmolive

In related news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at $529,729.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at $529,729.24. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at approximately $1,069,868.70. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock valued at $4,486,063 over the last 90 days. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CL. Bank of America raised their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Citigroup raised their price target on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Finally, Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $102.79.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.